Journal of Blood Medicine
Volume 7, 2016 - Issue
Open access
100
Views
14
CrossRef citations to date
0
Altmetric
Review
Therapeutic and routine prophylactic properties of rFactor VIII Fc (efraloctocog alfa, Eloctate®) in hemophilia A
Pratima Chowdary1 Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free Hospital, London, UKCorrespondence[email protected]
, Emma Fosbury1 Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free Hospital, London, UK
, Anne Riddell1 Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free Hospital, London, UK
& Mary Mathias1 Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free Hospital, London, UK;2 Haemophilia Centre, Great Ormond Street Hospital for Children, London, UK
Pages 187-198
|
Published online: 12 Sep 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.